{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:20:48Z","timestamp":1779247248586,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.xphs.2021.08.030","type":"journal-article","created":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T17:24:50Z","timestamp":1630257890000},"page":"3829-3837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["3D Printing and Dissolution Testing of Novel Capsule Shells for Use in Delivering Acetaminophen"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0700-711X","authenticated-orcid":false,"given":"Shantanu G.","family":"Gaurkhede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ositomiwa O.","family":"Osipitan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Dromgoole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7565-1340","authenticated-orcid":false,"given":"Sara A.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6321-6990","authenticated-orcid":false,"given":"Anthony J. Di","family":"Pasqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6141-2103","authenticated-orcid":false,"given":"Jia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2021.08.030_bib0001","doi-asserted-by":"crossref","unstructured":"Ali A, Ahmad U, Akhtar J. 3D printing in pharmaceutical sector: an overview. Intechopen. 2020. Available at: https:\/\/doi.org\/10.5772\/intechopen.90738. Accessed August 27, 2021","DOI":"10.5772\/intechopen.90738"},{"issue":"1-2","key":"10.1016\/j.xphs.2021.08.030_bib0002","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijpharm.2015.12.071","article-title":"3D printing in pharmaceutics: a new tool for designing customized drug delivery systems","volume":"499","author":"Goole","year":"2016","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2021.08.030_bib0003","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/pharmaceutics11120645","article-title":"Additive manufacturing of personalized pharmaceutical dosage forms via stereolithography","volume":"11","author":"Healy","year":"2019","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.xphs.2021.08.030_bib0004","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1208\/s12249-018-1075-3","article-title":"Influence of geometry on the drug release profiles of stereolithographic (SLA) 3D-printed tablet","volume":"19","author":"Martinez","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1-2","key":"10.1016\/j.xphs.2021.08.030_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijpharm.2016.03.016","article-title":"Stereolithographic (SLA) 3D printing of oral modified-release dosage forms","volume":"503","author":"Wang","year":"2016","journal-title":"Int J Pharms"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.030_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0168-3659(99)00224-2","article-title":"Multimechanism oral dosage forms fabricated by three-dimensional printing","volume":"66","author":"Rowe","year":"2000","journal-title":"J Cont Rel"},{"key":"10.1016\/j.xphs.2021.08.030_bib0007","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2018.11.048","article-title":"Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder","volume":"555","author":"Infanger","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.08.030_bib0008","first-page":"1","article-title":"3D Pharming: direct printing of personalized pharmaceutical tablets","volume":"2","author":"Acosta-V\u00e9lez","year":"2016","journal-title":"Polymer science"},{"key":"10.1016\/j.xphs.2021.08.030_bib0009","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2478\/amm-2013-0186","article-title":"FDM 3D Printing technology in manufacturing composite elements","volume":"58","author":"Dudek","year":"2013","journal-title":"Archives of Metallurgy and Materials"},{"issue":"8","key":"10.1016\/j.xphs.2021.08.030_bib0010","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s11095-016-1933-1","article-title":"Emergence of 3D printed dosage forms: opportunities and challenges","volume":"33","author":"Alhnan","year":"2016","journal-title":"Pharm Res."},{"key":"10.1016\/j.xphs.2021.08.030_bib0011","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ijpharm.2015.04.069","article-title":"Effect of geometry on drug release from 3D printed tablets","volume":"494","author":"Goyanes","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.08.030_bib0012","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1208\/s12249-011-9581-6","article-title":"A novel injection-molded capsular device for oral pulsatile delivery based on swellable\/erodible polymers","volume":"12","author":"Gazzaniga","year":"2011","journal-title":"APPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.030_bib0013","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.xphs.2017.10.021","article-title":"Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: screening polymers for drug release, drug-polymer miscibility and printability","volume":"107","author":"Solanki","year":"2018","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.030_bib0014","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/pharmaceutics10040203","article-title":"Advanced pharmaceutical applications of hot-melt extrusion coupled with fused deposition modelling (FDM) 3D printing for personalised drug delivery","volume":"10","author":"Tan","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1-2","key":"10.1016\/j.xphs.2021.08.030_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2017.07.064","article-title":"Patient acceptability of 3D printed medicines","volume":"530","author":"Goyanes","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.08.030_bib0016","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijpharm.2015.10.039","article-title":"Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing","volume":"496","author":"Goyanes","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.08.030_bib0017","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1021\/acs.molpharmaceut.5b00510","article-title":"3D Printing of medicines: engineeting novel oral devices with unique design and drug release characteristics","volume":"12","author":"Goyanes","year":"2015","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2021.08.030_bib0018","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.addr.2007.09.009","article-title":"Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration","volume":"60","author":"Cole","year":"2008","journal-title":"Adv Drug Del Rev"},{"key":"10.1016\/j.xphs.2021.08.030_bib0019","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2003"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.030_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpharm.2011.02.048","article-title":"Performance qualification of a new hypromellose capsule: part II. Disintegration and dissolution comparison between two types of hypromellose capsules","volume":"416","author":"Ku","year":"2011","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2021.08.030_bib0021","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1023\/B:PHAM.0000026430.73789.e6","article-title":"Wilding IR. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules","volume":"21","author":"Cole","year":"2004","journal-title":"Pharm Res"},{"issue":"7","key":"10.1016\/j.xphs.2021.08.030_bib0022","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/03639040600608888","article-title":"Evaluation and comparison of physicomechanical characteristics of gelatin and hypromellose capsules","volume":"32","author":"Missaghi","year":"2006","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2021.08.030_bib0023","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejps.2018.12.019","article-title":"The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: material considerations\u2013printability\u2013process modulation, with consecutive effects on in vitro release, stability and degradation","volume":"129","author":"Ilyes","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2021.08.030_bib0024","doi-asserted-by":"crossref","first-page":"120315","DOI":"10.1016\/j.ijpharm.2021.120315","article-title":"Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets","volume":"597","author":"Shi","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.08.030_bib0025","first-page":"119983","volume":"591","author":"Cheng","year":"2020","journal-title":"3D printing of extended-release tablets of theophylline using hydroxypropyl methylcellulose (HPMC) hydrogels"},{"issue":"1-2","key":"10.1016\/j.xphs.2021.08.030_bib0026","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijpharm.2016.12.049","article-title":"Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets","volume":"519","author":"Zhang","year":"2017","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2021.08.030_bib0027","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","article-title":"The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings","volume":"21","author":"Graham","year":"2013","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.xphs.2021.08.030_bib0028","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2125.1980.tb01812.x","article-title":"Kinetics and metabolism of paracetamol and phenacetin","volume":"10","author":"Prescott","year":"1980","journal-title":"Br J Clin Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.030_bib0029","first-page":"181","article-title":"Bioavailability of Ibuprofen from orally and rectally administered hydroxypropyl methyl cellulose capsules compared to corresponding gelatin capsules","volume":"11","author":"Honkanen","year":"2001","journal-title":"STP Pharma Sci"},{"issue":"12","key":"10.1016\/j.xphs.2021.08.030_bib0030","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1002\/jps.23315","article-title":"Novel starch-based PVA thermoplastic capsules for hydrophilic lipid-based formulations","volume":"101","author":"Misic","year":"2012","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2021.08.030_bib0031","article-title":"Creating PVA copolymer capsules","volume":"20","author":"Hoshi","year":"2008","journal-title":"Pharm Tech Eur"},{"issue":"5","key":"10.1016\/j.xphs.2021.08.030_bib0032","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1208\/s12248-016-9939-5","article-title":"Investigation of polymer-surfactant and polymer-drug-surfactant miscibility for solid dispersion","volume":"18","author":"Gumaste","year":"2016","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2021.08.030_bib0033","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ijbiomac.2020.05.110","article-title":"Moisture sorption and desorption properties of gelatin, HPMC and pullulan hard capsules","volume":"159","author":"Yang","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2021.08.030_bib0034","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ijpharm.2014.12.029","article-title":"Moisture diffusion and permeability characteristics of hydroxypropylmethylcellulose and hard gelatin capsules","volume":"478","author":"Barham","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.08.030_bib0035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ijpharm.2016.08.005","article-title":"Multi-methodological investigation of the variability of the microstructure of HPMC hard capsules","volume":"511","author":"Faulhammer","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.08.030_bib0036","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2017.10.008","article-title":"3D printed multi-compartment capsular devices for two-pulse oral drug delivery","volume":"268","author":"Maroni","year":"2017","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2021.08.030_bib0037","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1208\/s12248-019-0297-y","article-title":"First-principles and empirical approaches to predicting in vitro dissolution for pharmaceutical formulation and process development and for product release testing","volume":"21","author":"Zaborenk","year":"2019","journal-title":"AAPS J"},{"issue":"9","key":"10.1016\/j.xphs.2021.08.030_bib0038","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.xphs.2015.12.006","article-title":"Theoretical analysis of drug dissolution: I. solubility and intrinsic dissolution rate","volume":"105","author":"Shekunov","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2021.08.030_bib0039","unstructured":"Ultimaker PVA SDS. Ultimaker Support. Available at: https:\/\/support.ultimaker.com\/hc\/en-us\/articles\/360012664920-Ultimaker-PVA-SDS. Accessed December 19, 2020."},{"key":"10.1016\/j.xphs.2021.08.030_bib0040","unstructured":"CAS No. 9004-65-3 | Sigma-Aldrich. Available at: https:\/\/www.sigmaaldrich.com\/catalog\/search?interface=CAS+No.&term=9004-65-3&N=0+4294464392&mode=partialmax&focus=product&lang=en&region=US. Accessed December 19, 2020."},{"key":"10.1016\/j.xphs.2021.08.030_bib0041","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1021\/ma00195a097","article-title":"Cellulose\/Poly (vinyl alcohol) Blends: An estimation of thermodynamic polymer-polymer interaction by melting point depression analysis","volume":"22","author":"Nishio","year":"1989","journal-title":"Macromolecules"},{"key":"10.1016\/j.xphs.2021.08.030_bib0042","unstructured":"<1241> Water\u00acSolid Interactions in Pharmaceutical Systems (USP34-NF29 2S)."},{"key":"10.1016\/j.xphs.2021.08.030_bib0043","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10973-011-1664-9","article-title":"Thermo-physical characterization of Pharmacoat \u00ae603, Pharmacoat\u00ae615 and Mowiol\u00ae4-98","volume":"109","author":"Perfetti","year":"2012","journal-title":"J Therm Anal Calorim"},{"key":"10.1016\/j.xphs.2021.08.030_bib0044","series-title":"Ansel\u2019s Pharmaceutical Dosage Forms and Drug Delivery Systems","first-page":"203","article-title":"Chapter 7: Capsules","author":"Allen","year":"2018"},{"issue":"8","key":"10.1016\/j.xphs.2021.08.030_bib0045","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1023\/A:1007579221726","article-title":"The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules","volume":"17","author":"Meyer","year":"2000","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.030_bib0046","first-page":"11","article-title":"Paracetamol: Mechanism of action, applications and safety concern","volume":"71","author":"Jozwiak-Bebenista","year":"2014","journal-title":"Acta Pol Pharm"},{"key":"10.1016\/j.xphs.2021.08.030_bib0047","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejps.2013.08.039","article-title":"Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus","volume":"57","author":"Garbacz","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2021.08.030_bib0048","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3109\/03639045.2014.1002409","article-title":"Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules","volume":"41","author":"Al-Tabakha","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.030_bib0049","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/S1516-14392011005000033","article-title":"Evaluation of the solubility of the HPMC\/PVA blends in biological fluids in vitro","volume":"14","author":"Bianchi","year":"2010","journal-title":"Mat Res"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.030_bib0050","first-page":"16","article-title":"Development of PVA copolymer capsules","volume":"16","author":"Hoshi","year":"2004","journal-title":"Pharm Tech Eur"},{"key":"10.1016\/j.xphs.2021.08.030_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rinphs.2013.08.002","article-title":"Capsule shell material impacts the in vitro disintegration and dissolution behavior of a green tea extract","volume":"13","author":"Glube","year":"2013","journal-title":"Results Pharma Sci"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.030_bib0052","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/nano10020301","article-title":"Evaluation of acetaminophen release from biodegradable poly (Vinyl alcohol) (PVA) and nanocellulose films using a multiphase release mechanism","volume":"10","author":"O'donnell","year":"2020","journal-title":"Nanomaterials(Basel)"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.030_bib0053","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11095-007-9468-0","article-title":"Synergic effects of polymeric additives on dissolution and crystallization of acetaminophen","volume":"25","author":"Wen","year":"2008","journal-title":"Pharm Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2021.08.030_bib0054","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2011.12.034","article-title":"The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules","volume":"424","author":"Jones","year":"2012","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.030_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/03639040600685183","article-title":"Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy","volume":"33","author":"El-Malah","year":"2007","journal-title":"Drug Dev Ind Pharm"},{"issue":"3-4","key":"10.1016\/j.xphs.2021.08.030_bib0056","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejps.2006.11.008","article-title":"A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules","volume":"30","author":"Tuleu","year":"2007","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.030_bib0057","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1208\/s12249-020-01905-8","article-title":"3D Printing as a promising tool in personalized medicine","volume":"22","author":"Vaz","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.xphs.2021.08.030_bib0058","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/apm.12934","article-title":"Personalized medicine - concepts, technologies, and applications in inflammatory skin diseases","volume":"127","author":"Litman","year":"2019","journal-title":"Apmis"},{"key":"10.1016\/j.xphs.2021.08.030_bib0059","series-title":"Modern pharmaceutics Vol 2 - Applications and Advances","first-page":"493","article-title":"Dosage forms for personlaized medicine: from the simple to the complex","author":"Florence","year":"2009"},{"issue":"12","key":"10.1016\/j.xphs.2021.08.030_bib0060","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1515\/cclm-2018-0181","article-title":"Personalized laboratory medicine: a patient-centered future approach","volume":"56","author":"\u017ditnik","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.xphs.2021.08.030_bib0061","series-title":"4th IEEE Reg 8 Conf Hist Electrotechnol","article-title":"A short history of 3D printing, a technological revolution just started","author":"Savini","year":"2015"},{"issue":"3","key":"10.1016\/j.xphs.2021.08.030_bib0062","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jps.24305","article-title":"Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material","volume":"104","author":"Water","year":"2015","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921004639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921004639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:34:49Z","timestamp":1758360889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921004639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0022354921004639"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.08.030","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3D Printing and Dissolution Testing of Novel Capsule Shells for Use in Delivering Acetaminophen","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}